The expansion in Indore is well-aligned with Lupin Diagnostics’ commitment to improving access to high-quality, reliable, and advanced testing centres and home collection facilities at an affordable price
Ryzneuta is a novel dimeric G- CSF long-acting fusion protein without pegylation. The Biologics License Application (BLA) of Ryzneuta is currently under late-stage review by the US FDA for Chemotherapy-Induced Neutropenia (CIN)
Kauliv provides reusable and disposable pen2 device options to cater to the global market demand.
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
Transformation to pure-play Innovative Medicines company nears completion
The reliability of their products, evidenced by their inclusion in the WHO emergency use list, has further improved with the addition of Takara Bio's enzymes.
This dense phase often resembles liquid droplets exhibiting higher protein density and weaker molecular motion than the surrounding medium.
Subscribe To Our Newsletter & Stay Updated
